These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27788301)

  • 101. Temporal Trends of High-Intensity Statin Therapy Among Veterans Treated With Percutaneous Coronary Intervention.
    Bin Abdulhak AA; Vaughan-Sarrzin M; Kaboli P; Horwitz PA; Mosher H; Sigurdsson G; Walker NE; Wallace R; Robinson JG
    J Am Heart Assoc; 2018 Mar; 7(5):. PubMed ID: 29503265
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Prasugrel-Induced Thrombocytopenia After Percutaneous Coronary Intervention.
    Hashmi AT; Sabharwal N; Saxena A; Saradna A; Kamholz SL; Hollander G; Shani J
    Am J Ther; 2019; 26(3):e425-e426. PubMed ID: 30908301
    [No Abstract]   [Full Text] [Related]  

  • 103. Prasugrel for Japanese Patients With Ischemic Heart Disease in Long-Term Clinical Practice (PRASFIT-Practice II)　- A 3-Month Interim Analysis of a Postmarketing Observational Study.
    Nakamura M; Kozuma K; Kitazono T; Iizuka T; Sekine T; Shiosakai K; Usui I; Kogure S
    Circ J; 2019 Feb; 83(3):637-646. PubMed ID: 30674776
    [TBL] [Abstract][Full Text] [Related]  

  • 104. One-year efficacy and safety of routine prasugrel in patients with acute coronary syndromes treated with percutaneous coronary intervention: results of the prospective rijnmond collective cardiology research study.
    Yetgin T; Boersma E; Smits PC; de Vries AG; Huijskens E; Zijlstra F; van der Linden MMJM; van Geuns RJM;
    Neth Heart J; 2018 Aug; 26(7-8):393-400. PubMed ID: 29931649
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Prasugrel monotherapy after PCI with the SYNERGY stent in patients with chronic stable angina or stabilised acute coronary syndromes: rationale and design of the ASET pilot study.
    Kogame N; Modolo R; Tomaniak M; Cavalcante R; de Martino F; Tinoco J; Ribeiro EE; Mehran R; Campos CM; Onuma Y; Lemos PA; Serruys PW;
    EuroIntervention; 2019 Aug; 15(6):e547-e550. PubMed ID: 31012851
    [No Abstract]   [Full Text] [Related]  

  • 106. Temporal Trends and Site Variation in High-Risk Coronary Intervention and the Use of Mechanical Circulatory Support: Insights From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program.
    Bricker RS; Glorioso TJ; Jawaid O; Plomondon ME; Valle JA; Armstrong EJ; Waldo SW
    J Am Heart Assoc; 2019 Dec; 8(24):e014906. PubMed ID: 31813312
    [TBL] [Abstract][Full Text] [Related]  

  • 107. International survey of patients undergoing percutaneous coronary intervention and their attitudes toward pharmacogenetic testing.
    Pereira NL; So D; Bae JH; Chavez I; Jeong MH; Kim SW; Madan M; Graham J; O'Cochlain F; Pauley N; Lennon RJ; Bailey K; Hasan A; Baudhuin LM; Bell MR; Lerman A; Goodman S; Mathew V; Farkouh M; Rihal CS
    Pharmacogenet Genomics; 2019 Jun; 29(4):76-83. PubMed ID: 30724853
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Trends in Coded Indications for Percutaneous Coronary Interventions in Medicare and the Veterans Affairs After Implementation of Hospital-Level Reporting of Appropriate Use Criteria.
    Dayoub EJ; Nathan AS; Khatana SAM; Wadhera RK; Kolansky DM; Yeh RW; Giri J; Groeneveld PW
    Circ Cardiovasc Qual Outcomes; 2021 Apr; 14(4):e006887. PubMed ID: 33719490
    [TBL] [Abstract][Full Text] [Related]  

  • 109. The implications of cocaine use and associated behaviors on adverse cardiovascular outcomes among veterans: Insights from the VA Clinical Assessment, Reporting, and Tracking (CART) Program.
    Gunja A; Stanislawski MA; Barón AE; Maddox TM; Bradley SM; Vidovich MI
    Clin Cardiol; 2018 Jun; 41(6):809-816. PubMed ID: 29652077
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Appropriateness of Percutaneous Coronary Interventions in Patients With Stable Coronary Artery Disease in US Department of Veterans Affairs Hospitals From 2013 to 2015.
    Hess PL; Kini V; Liu W; Roldan P; Autruong P; Grunwald GK; O'Donnell C; Doll JA; Ho PM; Bradley SM
    JAMA Netw Open; 2020 Apr; 3(4):e203144. PubMed ID: 32315067
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Patient Symptoms and Stress Testing After Elective Percutaneous Coronary Intervention in the Veterans Affairs Health Care System.
    Kini V; Parks M; Liu W; Waldo SW; Ho PM; Bradley SM; Hess PL
    JAMA Netw Open; 2022 Jun; 5(6):e2217704. PubMed ID: 35727581
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Impact of severity of baseline thrombocytopenia on outcomes after percutaneous coronary interventions: Analysis from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program.
    Vallurupalli S; Hess E; Plomondon ME; Park K; Waldo SW; Agarwal S; Uretsky BF
    Catheter Cardiovasc Interv; 2022 Apr; 99(5):1491-1497. PubMed ID: 35253342
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Transitions of Care Among Patients Undergoing Percutaneous Coronary Intervention for Stable Angina: Insights From the Veterans Affairs Clinical Assessment Reporting and Tracking Program.
    Waldo SW; Glorioso TJ; Barón AE; Doll JA; Plomondon ME; Ho PM
    J Am Heart Assoc; 2022 Feb; 11(4):e024598. PubMed ID: 35156396
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Clinical and Anatomic Complexity of Patients Undergoing Coronary Intervention With and Without On-Site Surgical Capabilities: Insights From the Veterans Affairs Clinical Assessment, Reporting and Tracking (CART) Program.
    Waldo SW; Hebbe A; Grunwald GK; Doll JA; Schofield R
    Circ Cardiovasc Interv; 2021 Jan; 14(1):e009697. PubMed ID: 33354988
    [TBL] [Abstract][Full Text] [Related]  

  • 115. When high-volume PCI operators in high-volume hospitals move to lower volume hospitals-Do they still maintain high volume and quality of outcomes?
    Lu TH; Li ST; Liang FW; Lee JC; Yin WH
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):644-650. PubMed ID: 29086474
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Duration of Dual Antiplatelet Therapy After PCI: How Short Can We Go?
    Baber U; Angiolillo DJ
    JACC Cardiovasc Interv; 2020 Oct; 13(19):2263-2265. PubMed ID: 32950420
    [No Abstract]   [Full Text] [Related]  

  • 117. Comparison of Characteristics and Outcomes of Veterans With Stable Ischemic Heart Disease Enrolled in the COURAGE Trial Versus the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.
    Smilowitz NR; Carey EP; Shah B; Hartigan PM; Plomondon ME; Maron DJ; Maddox TM; Spertus JA; Mancini GBJ; Chaitman BR; Weintraub WS; Sedlis SP; Boden WE;
    Am J Cardiol; 2022 Oct; 180():1-9. PubMed ID: 35918234
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Adoption of prasugrel into routine practice: rationale and design of the Rijnmond Collective Cardiology Research (CCR) study in percutaneous coronary intervention for acute coronary syndromes.
    Yetgin T; van der Linden MM; de Vries AG; Smits PC; Boersma E; van Geuns RJ; Zijlstra F;
    Neth Heart J; 2014 Feb; 22(2):55-61. PubMed ID: 24072688
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Acquired Factor V Inhibitor with Hemorrhagic Symptoms after Prasugrel Hydrochloride Treatment.
    Sakatoku K; Takakuwa T; Miura A; Araki T; Fujitani Y; Yamamura R
    Acta Haematol; 2020; 143(5):478-480. PubMed ID: 31522179
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Elimination of Aspirin From PCI Pharmacotherapy.
    Agarwal SK; Agarwal S
    JACC Cardiovasc Interv; 2021 Jan; 14(2):230. PubMed ID: 33478642
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.